Human medicines European public assessment report (EPAR): Moventig, naloxegol, Date of authorisation: 07/12/2014, Revision: 16, Status: Authorised

Human medicines European public assessment report (EPAR): Moventig, naloxegol, Date of authorisation: 07/12/2014, Revision: 16, Status: Authorised

Metadata
Provider: 
European Medicines AgencyEuropean Medicines Agency
URL: 
https://www.ema.europa.eu/en/medicines/human/EPAR/moventighttps://www.ema.europa.eu/en/medicines/human/EPAR/moventig
Retrieved on: 
Tuesday, January 2, 2024
Information
Tags: 
People, Medical Subject Headings, Peripheral, Diarrhea, Flatulence, Marketing, European Commission, Agency, INN, Constipation, Risk, Movement, Opioid, ATC, Pain, International, European, OIC, Spinal cord, Headache, Nausea, Language, Brain, Abdominal pain, Laxative, Cancer, Disorder, Tablet, Chronic pain, Select, Patient, Safety, Naloxone, Anatomy, Medicine, Bowel obstruction, Risk management, IIA, CHMP, Medical device
Geotags: 
EUROPEAN UNION, EU
Summary
Key Points: 


Human medicines European public assessment report (EPAR): Moventig, naloxegol, Date of authorisation: 07/12/2014, Revision: 16, Status: Authorised

Copyright: 
2024 European Medicines Agency. All Rights Reserved.